FindMyKOL
Clinical trialNCT01965561CompletedPhase 4Interventional

Performance of Junctional Tourniquets in Normal Human Volunteers

NCT01965561 is a phase 4 interventional trial sponsored by United States Army Institute of Surgical Research. As of 21 Nov 2026, it is completed. It studies Hemorrhage. The registry lists an enrollment of 10 participants at 1 site in 1 country. The registry lists a start date of 31 Oct 2013 and a primary completion date of 31 Dec 2013.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01965561
FieldValue
Registry IDNCT01965561
StatusCompleted
PhasePhase 4
Study typeInterventional trial
Lead sponsorUnited States Army Institute of Surgical Research
Enrollment10
Registered sites1
Countries1
ConditionsHemorrhage
Start31 Oct 2013
Primary completion31 Dec 2013
Study completion31 Dec 2013
Last update posted13 Dec 2017

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Normal human adult volunteers wereused to investigate the performance of medical devices intended to stop junctional bleeding on the battlefield.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Texas, United States1 site
  • United States Army Institute of Surgical Research

    Forts Sam Houston

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 1 siteTX1FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01965561

Each answer restates registry values shown on this page.

What is NCT01965561?

NCT01965561 is a phase 4 interventional trial sponsored by United States Army Institute of Surgical Research. It studies Hemorrhage.

Who leads NCT01965561?

The registry names John F Kragh, MD (principal investigator, United States Army Institute of Surgical Research) as the overall official.

Where does NCT01965561 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT01965561 end?

The registry lists a primary completion date of 31 Dec 2013 and a study completion date of 31 Dec 2013. The sponsor last updated the record on 13 Dec 2017.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.